debt cap
valu usd unless otherwis note
respect result even slight
disrupt jlt acquisit
view organ growth pace slow bit expect
although still healthi level modest revenu
disrupt jlt acquisit like persist
like merit acquisit longer term consult trend quit
good margin improv strong across board remain
outperform share
estim pt revis ep estim
account upsid slightli better margin
assumpt adjust ep estim
reflect better margin introduc ep estim
rais price target
base ep ebitda/shar estim previou
price target base ep ebitda/shar
assumpt new multipl fairli consist peer
track expect marsh mclennan report
adjust oper ep vs last year exceed
estim consensu expect upsid
estim origin better-than-anticip risk insur
item note first quarter jlt includ
mmc oper result deal close april view
initi result bit mix mmc overal margin came
better expect organ growth slip bit
least deceler trace back disrupt
even still overal organ growth ri
plenti area strength includ asia pacif /canada
ri oper margin also impress basi point
despit jlt carri lower margin consult result
quit good organ growth signific strength oliv
wyman consult margin also expand basi point
y/i aid recent restructur action
posit meaning margin expans across segment
consult organ revenu growth trend improv nice vs
employe retent cost save jlt acquisit run
close manag expect
declin revenu disrupt jlt acquisit evid
risk insur servic organ growth trend
price prior trade day market close estimate unless otherwis note
bloomberg capit market estim upside/downside/target
base case assum adjust ep estim
consist commiss fee growth excess
trend solid revenu contribut jlt acquisit
good intern growth forecast adjust
oper margin assum solid margin
improv year price target approxim
year-end ep ebitda forecast
close recent trade multipl
upsid scenario assum commiss
fee growth nearli driven better-than-expect
penetr intern market improv
global econom climat better-than-anticip top
bottom-lin growth jlt acquisit
scenario realiz addit basi point margin
improv stem solid cost contain effort
ep ebitda forecast
downsid scenario assum commiss
fee growth could reflect challeng
econom new busi environ rel
expect brokerag consult unit
assum basi point margin deterior
rel expect due softer-than-anticip
perform greater-than-anticip disrupt
jlt acquisit downsid scenario assum multipl
approxim ep ebitda/shar
view marsh mclennan well posit solid
growth margin expans across ri
consult segment quarter ahead biggest near-
term focu integr larg jlt acquisit
alway integr risk associ
larg deal support strateg merit deal
view good long-term addit platform
think becom difficult broker
expand margin view compani well lever
margin improv even organ growth
rang expect restrain share buyback
 near term acceler pace
sector valuat risen recent month find
share attract global revenu earn
gain traction intern compani continu
grow significantli emerg market countri
key foreign market success build presenc
faster-grow region insur penetr rate
low rise
strength insur unit see sever reason
strong momentum marsh guy carpent
continu driven higher usag services/new
penetr marsh agenc favor macro
room margin expans compani shown
good track record realiz bottom-lin leverag
good organ sale growth trend see persist
jlt acquisit jlt acquisit expect
dilut near term like long-term prospect
potenti upsides/risk invest thesi
good expens disciplin coupl rise cost
environ certain insur broker think
mid-single-digit organ growth rate higher need
drive margin materi higher sale slip believ
margin expans could difficult achiev
currenc risk given global natur
book busi compani subject polit
currenc execut risk associ oper
across number differ platform
consult segment result consult segment
econom sensit see fluctuat due
chang project activ econom uncertainti
could weigh unit result
takeaway quarter
initi thought jlt integr first quarter jlt includ
mmc oper result deal close april view initi result
bit mix mmc overal margin came far better expect
organ growth slip bit least deceler trace back
area disrupt risk insur servic segment particularli legaci
jlt view level revenu breakag jlt acquisit fulli expect
lot move part deal said organ revenu declin
guy carpent pronounc expect merger size
cope fulli integr team put restructur action
custom uncertainti take time improv expect
disrupt could evid quarter even still believ merit
jlt deal attract long-term basi particularli increas
mmc exposur market like uk australia well specialti line
werent mani specif updat deal except integr go accord
manag plan million cost synergi target still expect end
employe turnov legaci jlt run close
bit year-ago level manag long-term annual target grow overal
organ revenu margin expans remain unchang follow
strong margin across risk insur ri segment although organ growth
slip riss organ growth pace slip track
peer mention deceler due revenu
disrupt expect close deal size guy carpent
obviou area impact organ revenu fall due time lower new
busi level second time quarterli organ revenu declin guy
carpent past decad aon organ growth reinsur suggest
market share lost quarter believ guy carpent strong
franchis rebound time expect revenu weak unit
persist marsh unit report respect organ growth
asia pacif canada lead way area intern
marsh show deceler emea organ growth flat price favor
impact across mani area overal price better trend
larg complex account big market posit despit slightli
slower organ growth trend rel recent quarter adjust oper margin
expans basi point ri impress view speak strong cost
contain jlt restructur program start expect visibl
benefit restructur action earli
consult deliv all-around good quarter organ growth consult
segment pick vs trend improv across unit
oliv wyman hit cylind organ growth quarter driven
broad-bas strength across region area tough comp double-
digit growth forecast organ growth mid- high-singl digit
environ remain conduc continu high level
corpor discretionari spend project work mercer organ growth
better organ growth rate although wealth unit includ defin
benefit consult remain drag overal consult segment margin strong
basi point y/i benefit recent restructur action mercer
restructur program schedul wrap end
revis ep estim account upsid
slightli better margin assumpt adjust ep estim
reflect better margin introduc ep estim
marsh mclennan report adjust oper ep vs last year
exceed estim consensu expect upsid
estim origin mostli better-than-anticip oper margin risk
insur servic segment report ep includ variou
restructur charg associ close jlt acquisit free cash flow
million vs mm due lower net incom work capit chang
minor interest expens subtract net incom total million vs million
higher million assumpt adjust tax rate vs
estim manag re-affirmed tax rate guidanc rang fx
headwind ep vs drag expect
drag result
compani report capit market estim
point y/i forecast compens benefit cost total
revenu basi point y/i oper expens total
revenu basi point total companywid revenu grew
billion revenu forecast fx three percentag point headwind top-
line result similar headwind seen march quarter manag anticip
immateri invest incom growth
risk insur servic segment highlight
organ revenu growth rate risk insur servic ri unit deceler
weaker forecast shortfal mainli
guy carpent unit
total ri revenu includ fiduciari incom increas billion close
billion assumpt
marsh unit organ growth vs forecast marsh
asia pacif unit led way organ growth canada also
solid latin america organ growth deceler
emea organ growth flat vs
guy carpent organ revenu fell forecast reflect time
y/i well forecast
compani report capit market estim
organ revenu consult unit rose vs well
expect consult total revenu billion better
mercer organ revenu grew vs flat bit better
assumpt mercer career organ growth pick
also report organ growth quarter wealth includ invest
manag defin benefit-rel consult report flat organ revenu
better declin regist march quarter
oliv wyman organ revenu impress vs far better
estim
consult segment adjust oper margin ex amort
basi point y/i fairli consist expect
earli marsh agenc unit announc acquisit lovitt touch
rank busi insur broker list accord bi magazin
lovitt touch revenu around million marsh agenc unit also
announc acquisit institut retir plan consult fiduciari firm
centurion centurion excess billion plan asset
mercer announc sale larg market health defin benefit
administr busi morneau shepel million follow sale mercer
still larg presenc healthcar consult variou avenu includ
mercer marketplac health benefit relat busi
repurchas million share cost million model
buyback
 cash equival increas sequenti billion
billion end march
goodwil intang asset increas billion end
billion march reflect higher intang close jlt acquisit
quarter rais quarterli dividend nearli
consist compani long-term state object rais
dividend double-digit clip year
total outstand debt million sequenti end june billion
mmc debt/capit ratio stand vs last
year million note due septemb manag
anticip let debt expir
price target base ep ebitda/shar forecast
multipl consist mmc recent trade rang peer multipl believ
slight premium valuat warrant strength platform grow intern
presenc much-improv balanc sheet opportun out-performance
top- bottom-lin perspect howev compani process integr
largest acquisit histori expect acquisit key valuat driver
price target support outperform recommend
risk rate price target
risk price target rate includ follow
insur price deterior global basi remain weak extend
period time
risk associ weak global economi softer corpor discretionari spend
risk insur servic consult segment
manag turnov inabl retain attract key produc time
industry-wid pressur overal insur brokerag commiss rate
global exposur currenc risk polit risk chang tax landscap foreign
integr risk associ acquisit includ build-out marsh
advers rule litig higher-than-expect claim
unexpect chang regulatori system unit state within
weaker-than-anticip integr larg jlt acquisit
marsh mclennan compani one world largest profession servic firm
revenu around billion global reach extend
countri marsh mclennan provid broad array servic includ insur
numer relat serv compani risk insur servic segment
includ marsh guy carpent special insur reinsur broker
placement well numer risk manag analyt servic compani
consult segment consist oliv wyman group mercer provid human
resourc consult manag consult outsourc variou consulting-rel
million except per share data
compens benefit
incom continu oper
spent buyback
compani report capit market estim
